Literature DB >> 21620967

Physical and catalytic properties of a peroxidase derived from cytochrome c.

Johannes Everse1, Chyong-Jy J Liu, Penelope W Coates.   

Abstract

Except for its redox properties, cytochrome c is an inert protein. However, dissociation of the bond between methionine-80 and the heme iron converts the cytochrome into a peroxidase. Dissociation is accomplished by subjecting the cytochrome to various conditions, including proteolysis and hydrogen peroxide (H(2)O(2))-mediated oxidation. In affected cells of various neurological diseases, including Parkinson's disease, cytochrome c is released from the mitochondrial membrane and enters the cytosol. In the cytosol cytochrome c is exposed to cellular proteases and to H(2)O(2) produced by dysfunctional mitochondria and activated microglial cells. These could promote the formation of the peroxidase form of cytochrome c. In this study we investigated the catalytic and cytolytic properties of the peroxidase form of cytochrome c. These properties are qualitatively similar to those of other heme-containing peroxidases. Dopamine as well as sulfhydryl group-containing metabolites, including reduced glutathione and coenzyme A, are readily oxidized in the presence of H(2)O(2). This peroxidase also has cytolytic properties similar to myeloperoxidase, lactoperoxidase, and horseradish peroxidase. Cytolysis is inhibited by various reducing agents, including dopamine. Our data show that the peroxidase form of cytochrome c has catalytic and cytolytic properties that could account for at least some of the damage that leads to neuronal death in the parkinsonian brain.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21620967     DOI: 10.1016/j.bbadis.2011.05.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Down-regulation of the mitochondrial matrix peptidase ClpP in muscle cells causes mitochondrial dysfunction and decreases cell proliferation.

Authors:  Sathyaseelan S Deepa; Shylesh Bhaskaran; Rojina Ranjit; Rizwan Qaisar; Binoj C Nair; Yuhong Liu; Michael E Walsh; Wilson C Fok; Holly Van Remmen
Journal:  Free Radic Biol Med       Date:  2015-12-23       Impact factor: 7.376

2.  Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Ana Luisa Gavito; Antonio Córdoba-Fernández; José Chacón; Ángel Martín de Pablos
Journal:  Antioxidants (Basel)       Date:  2022-05-30

3.  Peroxide-dependent analyte conversion by the heme prosthetic group, the heme Peptide "microperoxidase-11" and cytochrome C on chitosan capped gold nanoparticles modified electrodes.

Authors:  Aysu Yarman; Bettina Neumann; Maria Bosserdt; Nenad Gajovic-Eichelmann; Frieder W Scheller
Journal:  Biosensors (Basel)       Date:  2012-05-14

Review 4.  Post-Translational Modifications of Cytochrome c in Cell Life and Disease.

Authors:  Alejandra Guerra-Castellano; Inmaculada Márquez; Gonzalo Pérez-Mejías; Antonio Díaz-Quintana; Miguel A De la Rosa; Irene Díaz-Moreno
Journal:  Int J Mol Sci       Date:  2020-11-11       Impact factor: 5.923

5.  Metabolite profile resulting from the activation/inactivation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 2-methyltetrahydro-β-carboline by oxidative enzymes.

Authors:  Tomás Herraiz; Hugo Guillén; Juan Galisteo
Journal:  Biomed Res Int       Date:  2013-07-28       Impact factor: 3.411

6.  Comparative Analysis of Multiple Neurodegenerative Diseases Based on Advanced Epigenetic Aging Brain.

Authors:  Feitong Shi; Yudan He; Yao Chen; Xinman Yin; Xianzheng Sha; Yin Wang
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.